-SEC Filing
Keybanc Maintains Overweight on ThredUp, Raises Price Target to $32
Keybanc analyst Edward Yruma maintains ThredUp (NASDAQ:TDUP) with a Overweight and raises the price target from $22 to $32.
Related Posts
Sasol Ventures To Advance Decarbonisation Ambitions; Earmarks €50M Over The Next Five Years; Collaborates With Emerald Technology Ventures
Sasol has announced that it has established Sasol Ventures to advance Sasol's decarbonisation and 2050 net zero ambitions through venture capital. It will invest €50 million over the next five years, making it
Credit Suisse Maintains Outperform on AbCellera Biologics, Lowers Price Target to $49
Credit Suisse analyst Tiago Fauth maintains AbCellera Biologics (NASDAQ:ABCL) with a Outperform and lowers the price target from $51 to $49.
ASLAN Pharma Reports Scientific Collab With Dr. Emma Guttman-Yassky On Identification Of Co.’s ASLAN004-Specific Biomarkers
ASLAN Pharmaceuticals (NASDAQ:ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced a collaboration with renowned